https://mcmillan.ca/wp-content/uploads/2020/05/profile-default-mobile.jpg

Sasa Jarvis is a respected capital markets and securities lawyer. Her practice focuses primarily on corporate and securities law matters, including financings of public and private companies, mergers and acquisitions, corporate governance issues, and continuous disclosure obligations.

Representing clients in various industries, including technology, life sciences, and regulated industries, Sasa works extensively with clients in the mining and cannabis sectors.

As part of her mining practice, Sasa advises public and private companies with respect to property option agreements, acquisitions of mineral properties, asset purchase and sale transactions, as well as technical disclosure.

Sasa advises public and private clients in the cannabis industry on transactional and corporate compliance matters, primarily with a view to going public, raising funds, and continuing to comply with disclosure and other requirements. She has assisted clients in the cannabis space since the firm established its dedicated practice in 2016.



Representative Matters

  • Acted for Bright Minds Biosciences Inc. in connection with its prospectus and listing on the Canadian Securities Exchange, 2021
  • Acted for Bright Minds Biosciencess Inc. in an overnight marketed short form prospectus for gross proceeds of $25.9 million, March 2021
  • Acted for MJIC, Inc. in connection with its reverse takeover to form ManifestSeven Holdings Corporation, September 2020
  • Acted for Turmalina Metals Corp. in an overnight marketed prospectus offering for gross proceeds of $8,500,000, February 2020
  • Acted for Turmalina Metals Corp. in connection with its prospectus and listing on the TSX Venture Exchange, 2019
  • Acted for Aurora Cannabis Inc. in connection with its acquisition of Whistler Medical Marijuana Corporation valued at $175,000,000.
  • Acted for Harvest One Cannabis Inc. (formerly Harvest One Capital Inc.) in its qualifying transaction involving the acquisition of 100% of the issued and outstanding shares of each of United Greeneries Holdings Ltd. from MMJ PhytoTech Limited and Satipharm AG from PhytoTechMedical (UK) Pty Ltd., a wholly subsidiary of MMJ PhytoTech Limited, and a related brokered $25,000,000 subscription receipt offering
  • Acts for various TSX Venture Exchange and Canadian Securities Exchange listed issuers in brokered and non-brokered debt and equity financings
  • Acts for companies completing going public transactions including reverse takeovers on the TSX Venture Exchange and Canadian Securities Exchange
  • Acts for Capital Pool Companies and businesses in completing “qualifying transactions” pursuant to the TSX Venture Exchange CPC program
  • Acted for VMS Ventures Inc. while Royal Nickel Corporation was purchasing it for a total consideration of $21.1 million, April 2016

Speaking Engagements

“Legislative Update”, Advanced Securities 2020 Series, Continuing Legal Education Society of British Columbia

June 2020

News


Directorships & Affiliations

  • Past Co-Chair of SOGIC-BC, a section of the Canadian Bar Association in British Columbia
  • Law Society of British Columbia

Education & Admissions

2015
Called to the British Columbia bar
2014
Juris Doctor with Business Law Concentration University of British Columbia
2011
BA, Political Science and Modern European StudiesUniversity of British Columbia

Insights by Sasa Jarvis (12 Posts)

Exemption for Four Patients Opens Door Further for Therapeutic Use of Psilocybin

Aug 19, 2020

A legal update on psychedelics: four Canadians with late stage cancer receive approval to use psilocybin to treat
their end-of-life distress.

Psychedelics and Canada’s Regulatory Landscape

Jul 10, 2020

A primer on the emerging psychedelics industry and how it fits into Canada's legal framework.

Stop the Presses: Printing of Disclosure Documents May Be a Thing of the Past

Jan 22, 2020

A summary of the proposal by CSA to adopt an "access equals delivery" model for disclosure documents.

CSA Notes Inadequate Disclosure of Financial Interest in Cannabis M&A

Nov 15, 2019

Securities regulators provided guidance regarding disclosure of financial interests and conflicts of interest in Cannabis transactions

The Next Phase of Canadian Cannabis: What to Expect in 2019 and Beyond

Jun 21, 2019

On June 14, 2019, Health Canada unveiled its Final Regulations for New Cannabis Products

Divergent Regulatory Approaches to Cryptocurrency Offerings: Developments in Canada, the United States, and China

Oct 9, 2017

Divergent Regulatory Approaches to Cryptocurrency Offerings: Developments in Canada, the United States, and China

Ontario Government to Grow LCBO: Recreational Cannabis to be sold at Government Stores

Sep 8, 2017

Ontario Government to Grow LCBO: Recreational Cannabis to be sold at Government Stores

McMillan Advises on First Initial Coin Offering Granted Exemptive Relief by Canadian Securities Regulators

Sep 4, 2017

McMillan Advises on First Initial Coin Offering Granted Exemptive Relief by Canadian Securities Regulators

Canadian Securities Administrators Propose New Prospectus Exemption for Resale of Securities of a Foreign Issuer

Jul 10, 2017

Canadian Securities Administrators Propose New Prospectus Exemption for Resale of Securities of a Foreign Issuer

Compliant at this Time: Canada’s Options Regarding its Treaty Obligations and the Legalization and Regulation of Non-Medical Cannabis

Jul 6, 2017

Compliant at this Time: Canada's Options Regarding its Treaty Obligations and the Legalization and Regulation of Non-Medical Cannabis

Prohibition to Go Up in Smoke: Government of Canada Introduces Legislation to Legalize and Regulate Non-Medical Access to Cannabis

Apr 17, 2017

Prohibition to Go Up in Smoke: Government of Canada Introduces Legislation to Legalize and Regulate Non-Medical Access to Cannabis

Rights (offering) on the money: CSA announces changes to rights offering prospectus exemptions

Oct 7, 2015

Rights (offering) on the money: CSA announces changes to rights offering prospectus exemptions